Get the Stockscreener App
2.46
1.23%
0.03
After Hours:
2.46
Xbiotech Inc stock is traded at $2.46, with a volume of 6,391.
It is up +1.23% in the last 24 hours and up +6.49% over the past month.
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
See More
Previous Close:
$2.43
Open:
$2.45
24h Volume:
6,391
Relative Volume:
0.17
Market Cap:
$75.00M
Revenue:
$300.00K
Net Income/Loss:
$-45.54M
P/E Ratio:
-1.6468
EPS:
-1.4938
Net Cash Flow:
$-40.21M
1W Performance:
+5.13%
1M Performance:
+6.49%
6M Performance:
-3.15%
1Y Performance:
-22.64%
1-Day Range:
$2.45
$2.49
1-Week Range:
$2.28
$2.49
52-Week Range:
$2.09
$3.61
Xbiotech Inc Stock (XBIT) Company Profile
Name
Xbiotech Inc
Sector
Industry
Phone
512-386-2900
Address
5217 WINNEBAGO LANE, AUSTIN, TX
Compare XBIT vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBIT
Xbiotech Inc
|
2.46 | 74.09M | 300.00K | -45.54M | -40.21M | -1.4938 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-14-19 | Initiated | Piper Jaffray | Overweight |
| Apr-21-17 | Downgrade | Noble Financial | Buy → Hold |
| Jun-28-16 | Reiterated | Noble Financial | Buy |
Xbiotech Inc Stock (XBIT) Latest News
Aug PostEarnings: Is XBiotech Inc part of any major index2026 Big Picture & Daily Volume Surge Signals - baoquankhu1.vn
Insider Buy: Is XBiotech Inc stock risky to hold nowMarket Performance Summary & Capital Efficiency Focused Strategies - baoquankhu1.vn
XBiotech (NASDAQ:XBIT) Stock Passes Below Fifty Day Moving AverageShould You Sell? - MarketBeat
CEO Moves: Is XBiotech Inc likely to announce a buybackShare Buyback & Risk Managed Investment Signals - baoquankhu1.vn
Winners Losers: Can XBiotech Inc lead its sector in growth2026 Earnings Surprises & Growth Focused Entry Point Reports - baoquankhu1.vn
Wolverine World Wide Stock: Navigating Challenges in the Competitive Footwear Sector for Long-Term V - AD HOC NEWS
Published on: 2026-03-31 08:55:40 - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
XBiotech Inc stock faces biotech sector headwinds amid pipeline uncertainty and market volatility - AD HOC NEWS
Comparing XBiotech (NASDAQ:XBIT) & IN8bio (NASDAQ:INAB) - Defense World
If You Invested $1,000 in Xbiotech (XBIT) - Stock Titan
Bearish Setup: Does XBiotech Inc offer margin of safetyWeekly Trade Report & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Setup Watch: Why is XBiotech Inc stock going down2026 Selloffs & Real-Time Stock Movement Alerts - baoquankhu1.vn
Wolverine World Wide Stock (ISIN: US9840001002) Faces Headwinds Amid Footwear Market Shifts - AD HOC NEWS
XBiotech (NASDAQ:XBIT) Stock Price Passes Below Two Hundred Day Moving AverageWhat's Next? - MarketBeat
XBiotech Inc. 2025 Annual Report: Risks, Regulatory Challenges, and Competitive Landscape in True Human™ Antibody Drug Development - Minichart
XBiotech: Q4 Earnings Snapshot - marketscreener.com
XBiotech (NASDAQ: XBIT) details IL‑1α pipeline and cash use - Stock Titan
XBiotech 2025 10-K: $0.0M Revenue, $(1.49) EPS - TradingView
XBiotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Gains Recap: Is Kulicke and Soffa Industries Inc in accumulation or distribution phaseQuarterly Investment Review & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Gainers Report: Can DECK keep up with sector leadersJuly 2025 Snapshot & Comprehensive Market Scan Reports - baoquankhu1.vn
Aug Sentiment: Is XBiotech Inc likely to announce a buybackQuarterly Market Summary & Free Verified High Yield Trade Plans - baoquankhu1.vn
XBIT SEC FilingsXbiotech 10-K, 10-Q, 8-K Forms - Stock Titan
Should You Buy XBiotech Inc (XBIT) Today? Analysis, Price Targets, and 2026 Outlook. - Intellectia AI
XBIT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Does XBiotech Inc. offer margin of safetyJuly 2025 Big Picture & Real-Time Buy Zone Alerts - mfd.ru
What’s next for XBiotech Inc. stockJuly 2025 News Drivers & Reliable Momentum Entry Alerts - mfd.ru
Market Review: Can CASI Pharmaceuticals Inc maintain its current growth rateWeekly Investment Recap & Reliable Price Breakout Alerts - baoquankhu1.vn
XBIT PE Ratio & Valuation, Is XBIT Overvalued - Intellectia AI
XBIT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Should I average down on XBiotech Inc. stockMarket Sentiment Summary & Fast Moving Trade Plans - mfd.ru
How ACP stock expands through international markets2025 Year in Review & Real-Time Buy Signal Alerts - mfd.ru
XBiotech (NASDAQ:XBIT) Stock Price Passes Below 50-Day Moving AverageTime to Sell? - MarketBeat
Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Bolsamania
Sentiment Recap: Can XBiotech Inc lead its sector in growth2025 Price Targets & Long Hold Capital Preservation Plans - baoquankhu1.vn
Aug Technicals: Will XBiotech Inc benefit from seasonalityJuly 2025 Patterns & Long-Term Capital Growth Ideas - baoquankhu1.vn
XBiotech (NASDAQ:XBIT) Stock Crosses Above 50-Day Moving AverageWhat's Next? - MarketBeat
Highs Report: Is XBiotech Inc part of any major indexWeekly Profit Recap & Consistent Profit Alerts - baoquankhu1.vn
Market Moves: Is XBiotech Inc stock risky to hold nowPortfolio Return Summary & Entry and Exit Point Strategies - baoquankhu1.vn
mfd ru > 2026> Why is XBiotech Inc. stock going downJuly 2025 Market Mood & Daily Entry Point Alerts - mfd.ru
XBiotech (NASDAQ:XBIT) Shares Pass Above 50-Day Moving AverageHere's What Happened - MarketBeat
Panic Selling: Why is XBiotech Inc stock going downWeekly Market Outlook & Accurate Trade Setup Notifications - baoquankhu1.vn
Amazon stock trend 2025Rate Hike & Precise Entry and Exit Recommendations - bollywoodhelpline.com
Will XBiotech Inc. stock reach Wall Street targetsJuly 2025 PreEarnings & Precise Buy Zone Tips - Bollywood Helpline
Is CRBP stock attractive for ETFsJuly 2025 Chart Watch & Technical Pattern Recognition Alerts - bollywoodhelpline.com
Will XBiotech Inc. (4XB) stock outperform energy sector in 20252025 Pullback Review & Weekly Setup with High ROI Potential - bollywoodhelpline.com
Setup Watch: Is OppFi Inc Equity Warrant stock influenced by commodity pricesInsider Buying & Technical Pattern Based Signals - baoquankhu1.vn
Price Action: Will BURU benefit from government policyAnalyst Upgrade & AI Powered Market Entry Strategies - baoquankhu1.vn
Guidance Update: Is Endeavour Silver Corp affected by consumer sentimentMarket Risk Summary & AI Powered Market Entry Ideas - baoquankhu1.vn
US Market Wrap: How Leap Therapeutics Inc stock compares to growth peers2025 Market Overview & Verified Momentum Stock Alerts - Bộ Nội Vụ
Xbiotech Inc Stock (XBIT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):